SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-010161
Filing Date
2024-02-02
Accepted
2024-02-02 17:15:50
Documents
14
Period of Report
2024-01-31
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm245111d1_8k.htm   iXBRL 8-K 22892
  Complete submission text file 0001104659-24-010161.txt   195476

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ckpt-20240131.xsd EX-101.SCH 3027
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ckpt-20240131_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ckpt-20240131_pre.xml EX-101.PRE 22367
15 EXTRACTED XBRL INSTANCE DOCUMENT tm245111d1_8k_htm.xml XML 3616
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38128 | Film No.: 24592742
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)